References
- Miller DG. The Association of immune disease and malignant lymphoma. Ann Intern Med 1967; 66: 507–21
- Monson R R, Hall AP. Mortality among arthritics. J Chronic Dis 1976; 29: 459–67
- Isomäki H, Hakulinen T, Joutsenlahti U. Excess risk of lympho-mas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978; 31: 691–6
- Allebeck P. Increased mortality in rheumatoid arthritis. Scand J Rheumatol 1982; 11: 81–6
- Symmons D PM. Neoplasms of the immune system in rheumdtoid arthritis. Am J Med 1985; 78: 22–8, Suppl 1A
- Katusic S, Beard C M, Kurland L T, Weis J W, Bergstrahl E. Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J Med 1985; 78: 50–5, Suppl 1A
- Laakso M, Mutru O, Isomäki H, Koota K. Cancer mortality in patients with rheumatoid arthritis. J Rheumatol 1986; 13: 522–6
- Gridley G, McLaughlin J K, Ekbom A, Klareskog L, Adami H-O, Hacker D G, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307–11
- Hakala M, Pöllänen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic disease registered for drug reimbursement. J Rheumatol 1993; 20: 1674–8
- Epstein M A, Achong BG. The Epstein-Barr virus. Springer-Verlag, Berlin 1979
- Fox R I, Lotz M, Rhodes G, Vaughan JH. Epstein-Barr virus in rheumatoid arthritis. Clin Rheum Dis 1985; 11: 665–88
- Silman A J, Petrie J, Hazelman B, Evans S JW. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 1988; 47: 988–92
- Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 1985; 78: 15–21, Suppl 1A
- Heath CW, Jr. Rheumatoid arthritis, aspirin, and gastrointestinal cancer. J Natl Cancer Inst 1993; 85: 258–9